Oligomeric immunoglobulin A antibody response to rubella virus infection.
Pooled sera from rubella patients in the early convalescent stage, containing a high titer of hemagglutination-inhibiting (HI) antibody, were treated with protein A-conjugated gel to reduce immunoglobulin G (IgG) antibody and then centrifuged in sucrose gradients. This treatment resulted in the detection of an HI activity peak sedimenting at a rate intermediate between 7S and 19S. In contrast to the 19S antibody, the HI activity of this peak was not abolished by 2-mercaptoethanol, but sedimented at 7S after this treatment. The activity was considered to consist of IgA oligomers, since it was removed by anti-IgA immunosorbent. The appearance of the oligomeric IgA antibody after the infection was then studied using serum samples collected sequentially from five rubella patients. Shortly after the onset of the disease, the HI activity appeared at high titer and thereafter gradually decreased in titer until it could no longer be detected in the sera. The time of its disappearance varied with each patient.
D000914:Antibodies, Viral / Q000096:biosynthesis*; D003289:Convalescence; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis*; D008623:Mercaptoethanol / Q000494:pharmacology; D012409:Rubella / Q000276:immunology*; D012412:Rubella virus / Q000276:immunology*; D013205:Staphylococcal Protein A / Q000494:pharmacology
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D013205:Staphylococcal Protein A; D008623:Mercaptoethanol